Anoto Awarded Major Digital Pen Contract by the Welsh Ambulance Service Trust

AnotoAnoto, the leader in digital writing technology, today announced that the Welsh Ambulance Service Trust (WAST) has awarded a contract to roll-out 1,700 digital pens to ambulance crews across Wales. The contract that is led by Vodafone UK, is for an initial three year term and follows a highly successful pilot of Anoto's digital writing technology with paramedics at the Swansea Ambulance station in 2013. The total contractual value for Anoto is MSEK 10 and payment of the full amount is expected in April.

Each year in Wales, around 500,000 patient clinical records are completed by WAST's ambulance crews. As well as leaving a copy of the form with the patient at home or hospital a duplicate paper copy of the form is filed by the ambulance clinician at the end of their shift. These forms are transported to the WAST clinical audit department for scanning and data verification. This current process can take a considerable time and the management team at WAST need more timely clinical data on their interaction with patients in order to share information across the NHS, as well as drive and measure improvements in patient care.

There is very little change to current working practices with the introduction of digital pens, which is one of the reasons that the technology was chosen. Each team will be equipped with an Anoto digital pen, and they will complete the patient clinical record in the ambulance as per normal practice.

At the end of the patient encounter the crew will still leave a paper form with the patient; however there will now be no second duplicate copy to post back at the station. Instead the handwritten entries on the form are stored securely on the paramedic's encrypted digital pen. These will be transferred instantly to the clinical audit department as soon as they dock their digital pen at the hospital or back at the station at the end of their shift.

During 2013, WAST evaluated a range of technologies, including tablet devices, to generate a digital patient record and concluded that the Anoto pen was the best fit for its patient data capture requirements.

Commenting on this decision, Richard Lee, head of clinical services at WAST said: "Digital Pens were the most popular option with our paramedic staff. Our staff are focused on delivering care to their patients and need to be able to keep accurate records of observations taken or medications administered. We needed a way of capturing data which was fast and easy so that it doesn't distract from the staffs primary focus on the patient.

"This solution delivers just what we need; a secure digital patient record that can be rapidly transferred to our clinical audit department. Measuring the quality of the care given by ambulance crews for conditions such as stroke or heart attack is increasingly important in order that we manage the whole patient episode from 999 call to definitive treatment.

"Digital pen-technology will drive significant improvements in our reporting capabilities and the way we measure the quality of the care we provide. We know that these devices are easy for our staff to use, and still allow the ambulance crew to focus on their patients rather than having to stare at a computer screen. It will also enable us to cut our use of paper by 50%."

Stein Revelsby, CEO at Anoto Group said: "This will be our largest digital pen roll out in the NHS to date. Anoto digital writing solutions for paper and displays combine the intuitive precision of writing with a normal pen together with the efficiency gains from immediate electronic transfer of data and information. Healthcare continues to be an important market for Anoto Enterprise Solutions and our partners."

Future developments under consideration include integration of the Anoto digital pen solution with an all-Wales Emergency Department system and also transfer of digital pen data from ambulances on route using the Vodafone mobile network.

About Anoto Group
Anoto Group is the company behind and world leading in the unique technology for digital pen and paper, which enables fast and reliable transmission of handwritten text into a digital format.

Anoto operates through a global partner network that focuses on user-friendly solutions for efficient capture, transmission and storage of data within different business segments, e.g. healthcare, bank and finance, transport and logistics and education. The Anoto Group has over 100 employees and is headquartered in Lund (Sweden), with offices in Basingstoke and Wetherby (UK), Boston and Los Angeles (US) and Tokyo (Japan). The Anoto share is traded on the Small Cap list of NASDAQ OMX Stockholm under the ticker ANOT.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...